Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.
Quicktake – Purple Biotech (PPBT) | Biotech Investment Blog | biotickr
Purple Biotech Ltd., a clinical-stage company, is developing treatments for cancers to overcome drug resistance. The lead oncology asset CM24 is a monoclonal antibody that